相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vitro Mesenchymal Progenitor Cell Expansion is a Predictor of Transplant-related Mortality and acute GvHD III-IV After Bone Marrow Transplantation in Univariate Analysis: A Large Single-Center Experience
Massimo Berger et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2019)
Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
Zujun Que et al.
CANCER CELL INTERNATIONAL (2019)
Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma
Seung Ah Choi et al.
CANCER LETTERS (2019)
DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death
Hyeonjeong Lee et al.
CANCER RESEARCH (2019)
Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
Baojie Zhang et al.
CANCERS (2019)
MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells
Andrea Mohr et al.
CANCERS (2019)
Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and TRAIL and suppress the growth of H460 human lung cancer cells
Pil Young Jung et al.
CANCER LETTERS (2019)
Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study
Shayesteh Khalifeh Soltani et al.
CYTOTHERAPY (2019)
Optimizing the transport and storage conditions of current Good Manufacturing Practice - grade human umbilical cord mesenchymal stromal cells for transplantation (HUC-HEART Trial)
Ferda Topal Celikkan et al.
CYTOTHERAPY (2019)
TRAIL inhibits platelet-induced colorectal cancer cell invasion
Li-Sha Wu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
Human Dental Pulp Stem Cells and Gingival Mesenchymal Stem Cells Display Action Potential Capacity In Vitro after Neuronogenic Differentiation
Dong Li et al.
STEM CELL REVIEWS AND REPORTS (2019)
The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme
Ezgi Kaya-Aksoy et al.
CELL DEATH DISCOVERY (2019)
Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells
Annekathrin Reinhardt et al.
ANTICANCER RESEARCH (2018)
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
Peter Bader et al.
BONE MARROW TRANSPLANTATION (2018)
Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation
Olivier Micheau
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
miR-27a is highly expressed in H1650 cancer stem cells and regulates proliferation, migration, and invasion
Wenwen Luo et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
The enhanced delivery of salinomycin to CD133+ ovarian cancer stem cells through CD133 antibody conjugation with poly( lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles
Yi Mi et al.
ONCOLOGY LETTERS (2018)
Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model
Xiaoyi Liu et al.
ONCOLOGY LETTERS (2018)
Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas
Vivian P. Wagner et al.
SCIENTIFIC REPORTS (2018)
Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles
Tamoghna Mandal et al.
SCIENTIFIC REPORTS (2018)
The Regulation of Differentiation of Mesenchymal Stem-cells into Skeletal Muscle: A Look at Signalling Molecules Involved in Myogenesis
B. Hodgson et al.
CURRENT STEM CELL RESEARCH & THERAPY (2018)
Inhibition of NF-kappa B Signaling Reduces the Sternness Characteristics of Lung Cancer Stem Cells
Norashikin Zakaria et al.
FRONTIERS IN ONCOLOGY (2018)
TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy
Jieun Han et al.
BIOMATERIALS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
Kamal Shaik Fakiruddin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model
Fazileh Hosseini Shamili et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Targeting lung cancer initiating cells by all-trans retinoic acid-loaded lipid-PLGA nanoparticles with CD133 aptamers
Yu Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial
Mohsen Emadedin et al.
CYTOTHERAPY (2018)
Anti-tumour effects of TRAIL-expressing human placental derived mesenchymal stem cells with curcumin-loaded chitosan nanoparticles in a mice model of triple negative breast cancer
Mohammad Kamalabadi-Farahani et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting
Yuanyuan Li et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells Single Center Experience
Maja Cesen Mazic et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2018)
Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells
Soumyabrata Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
Florent Dufour et al.
ONCOTARGET (2017)
miR-181b-5p mediates TGF-β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells
Xuetao Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133+ Lung Carcinoma A549 Cells
Li-Zhou Fang et al.
ONCOLOGY RESEARCH (2017)
Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
Xiaolong Huang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
Lauren MacDonagh et al.
ONCOTARGET (2017)
pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo
Paola Cafforio et al.
STEM CELL RESEARCH & THERAPY (2017)
Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease
Katari Venkatesh et al.
CURRENT STEM CELL RESEARCH & THERAPY (2017)
Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine
Rebekah M. Samsonraj et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?
Paul Lohan et al.
FRONTIERS IN IMMUNOLOGY (2017)
Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer
Lindsay M. Kuroki et al.
PLOS ONE (2017)
Personalised medicine for nonsmall cell lung cancer
Celine Mascaux et al.
EUROPEAN RESPIRATORY REVIEW (2017)
MiR-129-5p inhibits non-small cell lung cancer cell sternness and chemoresistance through targeting DLK1
Zheng Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting
Kiyoung Eun et al.
BMB REPORTS (2017)
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
Florent Dufour et al.
CELL DEATH AND DIFFERENTIATION (2017)
Targeting CD133+ laryngeal carcinoma cells with chemotherapeutic drugs and siRNA against ABCG2 mediated by thermo/pH-sensitive mesoporous silica nanoparticles
Xinmeng Qi et al.
TUMOR BIOLOGY (2016)
Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
Sin-Tzu Ning et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Nanomaterials in the Aquatic Environment: A European Union-United States Perspective on the Status of Ecotoxicity Testing, Research Priorities, and Challenges Ahead
Henriette Selck et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2016)
Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2
Wensi Zhao et al.
MOLECULAR MEDICINE REPORTS (2016)
Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
Su-Hoon Lee et al.
ONCOLOGY RESEARCH (2016)
Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse
Adam Nowakowski et al.
STEM CELLS AND DEVELOPMENT (2016)
Role of the crystalline form of titanium dioxide nanoparticles: Rutile, and not anatase, induces toxic effects in Balb/3T3 mouse fibroblasts
Chiara Uboldi et al.
TOXICOLOGY IN VITRO (2016)
Side population cells from long-term passage non-small cell lung cancer cells display loss of cancer stem cell-like properties and chemoradioresistance
Hao Gu et al.
ONCOLOGY LETTERS (2016)
The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis
Engeng Chen et al.
ONCOTARGET (2016)
Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
Norashikin Zakaria et al.
BMC CANCER (2015)
Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers
Valentina Hoyos et al.
MOLECULAR THERAPY (2015)
Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats
Gang Xu et al.
ONCOLOGY REPORTS (2015)
Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro
Xiaoyi Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
Valerio Leoni et al.
ONCOTARGET (2015)
Trailing TRAIL resistance: novel a gets for TRAIL sensitization in cancer cells
Rachana Trivedi et al.
FRONTIERS IN ONCOLOGY (2015)
Gene-Directed Enzyme Prodrug Therapy
Jin Zhang et al.
AAPS JOURNAL (2015)
Combination of Systemic Chemotherapy with Local Stem Cell Delivered S-TRAIL in Resected Brain Tumors
Navid Redjal et al.
STEM CELLS (2015)
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
A. C. Murphy et al.
APOPTOSIS (2014)
Flow Cytometric Analysis of CD133-and EpCAM-Positive Cells in the Peripheral Blood of Patients with Lung Cancer
Tomasz Skirecki et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Producing IL15 Eradicate Established Pancreatic Tumor in Syngeneic Mice
Wei Jing et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells
Yang Shi et al.
PLOS ONE (2014)
Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
In-Sun Hong et al.
Recent Patents on Anti-Cancer Drug Discovery (2014)
Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
Elizabeth K. Sage et al.
THORAX (2014)
Evaluation of gene delivery strategies to efficiently overexpress functional HLA-G on human bone marrow stromal cells
Joana S. Boura et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Engineering death receptor ligands for cancer therapy
Harald Wajant et al.
CANCER LETTERS (2013)
Targeting apoptosis pathways in cancer stem cells
Michele Signore et al.
CANCER LETTERS (2013)
Cisplatin Selects for Multidrug-Resistant CD133(+) Cells in Lung Adenocarcinoma by Activating Notch Signaling
Yu-Peng Liu et al.
CANCER RESEARCH (2013)
TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo
Benny Perlstein et al.
NEURO-ONCOLOGY (2013)
Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
Martin P. Barr et al.
PLOS ONE (2013)
Growth kinetics of CD133-positive prostate cancer cells
Edwin E. Reyes et al.
PROSTATE (2013)
Mesenchymal Stem Cells Isolated from Peripheral Blood and Umbilical Cord Wharton's Jelly
Drenka Trivanovic et al.
SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO (2013)
Relating Cytotoxicity, Zinc Ions, and Reactive Oxygen in ZnO NanoparticleExposed Human Immune Cells
Cenchao Shen et al.
TOXICOLOGICAL SCIENCES (2013)
Lung cancer tumorigenicity and drug resistance are enhanced through ALDHhiCD44hi tumor initiating cells
Jing Liu et al.
ONCOTARGET (2013)
TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells
M. R. Moniri et al.
CANCER GENE THERAPY (2012)
CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component
Ulf D. Kahlert et al.
FOLIA NEUROPATHOLOGICA (2012)
Cellular signal transduction can be induced by TRAIL conjugated to microcapsules
Margaret A. Wheatley et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2012)
Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ
Michaela R. Reagan et al.
JOURNAL OF BREAST CANCER (2012)
Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer
Yong Zhang et al.
ONCOLOGY REPORTS (2012)
Targeting the extrinsic apoptosis signaling pathway for cancer therapy
Thomas J. Sayers
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
Atique U. Ahmed et al.
MOLECULAR PHARMACEUTICS (2011)
Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma
Seung Ah Choi et al.
NEURO-ONCOLOGY (2011)
Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity
Shailaja Akunuru et al.
PLOS ONE (2011)
Side Population is Not Necessary or Sufficient for a Cancer Stem Cell Phenotype in Glioblastoma Multiforme
Kate W. R. Broadley et al.
STEM CELLS (2011)
TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
M. R. Loebinger et al.
BRITISH JOURNAL OF CANCER (2010)
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
Giulia Grisendi et al.
CANCER RESEARCH (2010)
Characterization of the Intestinal Cancer Stem Cell Marker CD166 in the Human and Mouse Gastrointestinal Tract
Trevor G. Levin et al.
GASTROENTEROLOGY (2010)
Adipose Tissue-derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth
Ilaria T. Cavarretta et al.
MOLECULAR THERAPY (2010)
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Elaine Lai-Han Leung et al.
PLOS ONE (2010)
Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells
Andrea Mohr et al.
STEM CELLS (2010)
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
Monzur Rahman et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Michael R. Loebinger et al.
CANCER RESEARCH (2009)
Stem cells are resistant to TRAIL receptor-mediated apoptosis
Eva Szegezdi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang et al.
MOLECULAR CANCER RESEARCH (2009)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Laura S. Sasportas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
Giulia Bertolini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation
Lei Fang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Identification and expansion of the tumorigenic lung cancer stem cell population
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2008)
The Proteasome Inhibitor MG132 Sensitizes Lung Cancer Cells to TRAIL-induced Apoptosis by Inhibiting NF-k B Activation
Pil Won Seo et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2008)
TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib
Jens Voortman et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors
Tanja Hakkarainen et al.
HUMAN GENE THERAPY (2007)
Adipose-derived stem cells for regenerative medicine
Jeffrey M. Gimble et al.
CIRCULATION RESEARCH (2007)
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells:: impact on in vivo tumor growth
R. Ramasamy et al.
LEUKEMIA (2007)
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Alma J. Nauta et al.
BLOOD (2006)
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Aarif Y. Khakoo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells
An Van Damme et al.
STEM CELLS (2006)
Controversy - Fighting cancer with oncolytic viruses
Y Chernajovsky et al.
BRITISH MEDICAL JOURNAL (2006)
tRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality
Nadia Corazza et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
N Eliopoulos et al.
BLOOD (2005)
Bone marrow-derived mesenchymal stem cells
KC Kemp et al.
LEUKEMIA & LYMPHOMA (2005)
Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro
WR Xu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2004)
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y
T Hirose et al.
ONCOGENE (2003)
Human mesenchymal stem cells maintain transgene expression during expansion and differentiation
K Lee et al.
MOLECULAR THERAPY (2001)
The role of NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells
AV Franco et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
